Copyright Reports & Markets. All rights reserved.

Global β-blockers Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of β-blockers

      • 1.1 Definition of β-blockers
      • 1.2 β-blockers Segment by Type
        • 1.2.1 Global β-blockers Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Nonselective Agents
        • 1.2.3 Selective Agents
      • 1.3 β-blockers Segment by Applications
        • 1.3.1 Global β-blockers Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Abnormal Heart Rhythms
        • 1.3.3 Hypertension
      • 1.4 Global β-blockers Overall Market
        • 1.4.1 Global β-blockers Revenue (2014-2025)
        • 1.4.2 Global β-blockers Production (2014-2025)
        • 1.4.3 North America β-blockers Status and Prospect (2014-2025)
        • 1.4.4 Europe β-blockers Status and Prospect (2014-2025)
        • 1.4.5 China β-blockers Status and Prospect (2014-2025)
        • 1.4.6 Japan β-blockers Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia β-blockers Status and Prospect (2014-2025)
        • 1.4.8 India β-blockers Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of β-blockers
      • 2.3 Manufacturing Process Analysis of β-blockers
      • 2.4 Industry Chain Structure of β-blockers

      3 Development and Manufacturing Plants Analysis of β-blockers

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global β-blockers Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of β-blockers
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 β-blockers Production and Capacity Analysis
      • 4.2 β-blockers Revenue Analysis
      • 4.3 β-blockers Price Analysis
      • 4.4 Market Concentration Degree

      5 β-blockers Regional Market Analysis

      • 5.1 β-blockers Production by Regions
        • 5.1.1 Global β-blockers Production by Regions
        • 5.1.2 Global β-blockers Revenue by Regions
      • 5.2 β-blockers Consumption by Regions
      • 5.3 North America β-blockers Market Analysis
        • 5.3.1 North America β-blockers Production
        • 5.3.2 North America β-blockers Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America β-blockers Import and Export
      • 5.4 Europe β-blockers Market Analysis
        • 5.4.1 Europe β-blockers Production
        • 5.4.2 Europe β-blockers Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe β-blockers Import and Export
      • 5.5 China β-blockers Market Analysis
        • 5.5.1 China β-blockers Production
        • 5.5.2 China β-blockers Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China β-blockers Import and Export
      • 5.6 Japan β-blockers Market Analysis
        • 5.6.1 Japan β-blockers Production
        • 5.6.2 Japan β-blockers Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan β-blockers Import and Export
      • 5.7 Southeast Asia β-blockers Market Analysis
        • 5.7.1 Southeast Asia β-blockers Production
        • 5.7.2 Southeast Asia β-blockers Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia β-blockers Import and Export
      • 5.8 India β-blockers Market Analysis
        • 5.8.1 India β-blockers Production
        • 5.8.2 India β-blockers Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India β-blockers Import and Export

      6 β-blockers Segment Market Analysis (by Type)

      • 6.1 Global β-blockers Production by Type
      • 6.2 Global β-blockers Revenue by Type
      • 6.3 β-blockers Price by Type

      7 β-blockers Segment Market Analysis (by Application)

      • 7.1 Global β-blockers Consumption by Application
      • 7.2 Global β-blockers Consumption Market Share by Application (2014-2019)

      8 β-blockers Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer β-blockers Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis β-blockers Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck β-blockers Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Astra Zeneca
        • 8.4.1 Astra Zeneca β-blockers Production Sites and Area Served
        • 8.4.2 Astra Zeneca Product Introduction, Application and Specification
        • 8.4.3 Astra Zeneca β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Jhonson and Johnson
        • 8.5.1 Jhonson and Johnson β-blockers Production Sites and Area Served
        • 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
        • 8.5.3 Jhonson and Johnson β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly
        • 8.6.1 Eli Lilly β-blockers Production Sites and Area Served
        • 8.6.2 Eli Lilly Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi β-blockers Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb
        • 8.8.1 Bristol-Myers Squibb β-blockers Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bayer
        • 8.9.1 Bayer β-blockers Production Sites and Area Served
        • 8.9.2 Bayer Product Introduction, Application and Specification
        • 8.9.3 Bayer β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 GSK
        • 8.10.1 GSK β-blockers Production Sites and Area Served
        • 8.10.2 GSK Product Introduction, Application and Specification
        • 8.10.3 GSK β-blockers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical

      9 Development Trend of Analysis of β-blockers Market

      • 9.1 Global β-blockers Market Trend Analysis
        • 9.1.1 Global β-blockers Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 β-blockers Regional Market Trend
        • 9.2.1 North America β-blockers Forecast 2019-2025
        • 9.2.2 Europe β-blockers Forecast 2019-2025
        • 9.2.3 China β-blockers Forecast 2019-2025
        • 9.2.4 Japan β-blockers Forecast 2019-2025
        • 9.2.5 Southeast Asia β-blockers Forecast 2019-2025
        • 9.2.6 India β-blockers Forecast 2019-2025
      • 9.3 β-blockers Market Trend (Product Type)
      • 9.4 β-blockers Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 β-blockers Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        β-blockers are a class of medications that are predominantly used to manage abnormal heart rhythms, and to protect the heart from a second heart attack (myocardial infarction) after a first heart attack (secondary prevention). They are also widely used to treat high blood pressure (hypertension), although they are no longer the first choice for initial treatment of most patients.

        The global β-blockers market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on β-blockers volume and value at global level, regional level and company level. From a global perspective, this report represents overall β-blockers market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of β-blockers in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their β-blockers manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Merck
        Astra Zeneca
        Jhonson and Johnson
        Eli Lilly
        Sanofi
        Bristol-Myers Squibb
        Bayer
        GSK
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Nonselective Agents
        Selective Agents

        Segment by Application
        Abnormal Heart Rhythms
        Hypertension

        Buy now